Differential responses of males and females to multi-walled carbon nanotubes

Information

  • Research Project
  • 10266754
  • ApplicationId
    10266754
  • Core Project Number
    R21ES030978
  • Full Project Number
    5R21ES030978-02
  • Serial Number
    030978
  • FOA Number
    PA-19-053
  • Sub Project Id
  • Project Start Date
    9/18/2020 - 4 years ago
  • Project End Date
    8/31/2022 - 2 years ago
  • Program Officer Name
    RAVICHANDRAN, LINGAMANAIDU V
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/26/2021 - 3 years ago
Organizations

Differential responses of males and females to multi-walled carbon nanotubes

Abstract Adverse outcomes following the inhalation of engineered nanomaterials, such as multi-walled carbon nanotubes (MWCNTs), have been identified in occupational settings. Unfortunately, long-term consequences and sensitive populations remain undefined. Chronic respiratory diseases often demonstrate sex-biases in disease prevalence. For example, asthma occurs more often and with increased severity in adult women compared to men. Our preliminary studies indicate that the outcomes of MWCNT exposure follow this trend: there is increased lung inflammation and injury in females compared to males. Therefore, it is logical and necessary to investigate the biological factors that may contribute to these sex-differences. There is experimental and clinical evidence that sex-steroid hormones influence the development of lung disease. A likely target of hormone signaling is alveolar macrophages (AMs), the primary resident immune cell within the lungs. The phenotype and function of AMs is an important factor in promoting specific immune responses to inhaled materials, and may contribute to inadvertent immune-mediated lung injury. This project will investigate the role of hormone signaling on AM phenotype and how this contributes to impaired lung function after exposure to MWCNTs. Current literature suggests that estrogen receptor a (ERa) signaling promotes an exaggerated M2a macrophage phenotype. The M2a phenotype promotes antibody production by B cells and is therefore associated with allergy and asthma; MWCNTs have also been shown to induce an M2a phenotype in AMs. Amplification of M2a phenotype polarization can lead to increased production of signaling molecules that cause inappropriate immune cell recruitment and inflammation, which eventually results in increased lung injury and decreased function. These data, combined with our preliminary results, provides a potential hormone-dependent mechanism for the increased susceptibility of women to allergens and nanomaterials. This project will address the hypothesis that estrogen signaling through ERa promotes an exaggerated M2a phenotype in female AMs, which contributes to the increased occurrence and severity of particle-induced respiratory diseases in women.

IC Name
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
  • Activity
    R21
  • Administering IC
    ES
  • Application Type
    5
  • Direct Cost Amount
    125000
  • Indirect Cost Amount
    57034
  • Total Cost
    182034
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    113
  • Ed Inst. Type
    SCHOOLS OF PHARMACY
  • Funding ICs
    NIEHS:182034\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    SIEE
  • Study Section Name
    Systemic Injury by Environmental Exposure
  • Organization Name
    UNIVERSITY OF MONTANA
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    010379790
  • Organization City
    MISSOULA
  • Organization State
    MT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    598124104
  • Organization District
    UNITED STATES